Groupe la Francaise »

Catalyst Pharmaceutical Partners shares owned by Groupe la Francaise

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Groupe la Francaise from 13F filings

Historical chart of Groupe la Francaise investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Groupe la Francaise consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Groupe la Francaise

Quarter filed Position value Share count Share price at filing
2026-06-30 $8.1M 257k 31.43

More positions owned by Groupe la Francaise

NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Totalenergies Se Act (TTE)
Apple (AAPL)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Eli Lilly & Co. (LLY)
Visa Com Cl A (V)
Alphabet Cap Stk Cl C (GOOG)
Astrazeneca Ord (AZN)
Taiwan Semiconductor Manufac Sponsored Ads (TSM)
Meta Platforms Cl A (META)
Cgi Cl A Sub Vtg (GIB)

View all positions for Groupe la Francaise

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
State Street Corporation
American Century Companies
Vanguard Capital Management
Dimensional Fund Advisors
Glazer Capital
Jpmorgan Chase & Co
Geode Capital Management
HBK Investments
Morgan Stanley
Vanguard Portfolio Management
Jupiter Topco
Qube Research & Technologies
Renaissance Technologies
Henderson Group

View all funds holding Catalyst Pharmaceutical Partners